Alpha-1 Lung Disease Market - Global Outlook and Forecast 2021-2027

Alpha-1 Lung Disease Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Alpha-1 Lung Disease Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alpha-1 Lung Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alpha-1 Lung Disease Overall Market Size
2.1 Global Alpha-1 Lung Disease Market Size: 2021 VS 2027
2.2 Global Alpha-1 Lung Disease Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Alpha-1 Lung Disease Players in Global Market
3.2 Top Global Alpha-1 Lung Disease Companies Ranked by Revenue
3.3 Global Alpha-1 Lung Disease Revenue by Companies
3.4 Top 3 and Top 5 Alpha-1 Lung Disease Companies in Global Market, by Revenue in 2020
3.5 Global Companies Alpha-1 Lung Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alpha-1 Lung Disease Players in Global Market
3.6.1 List of Global Tier 1 Alpha-1 Lung Disease Companies
3.6.2 List of Global Tier 2 and Tier 3 Alpha-1 Lung Disease Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Alpha-1 Lung Disease Market Size Markets, 2021 & 2027
4.1.2 Augmentation Therapy
4.1.3 Cystic Fibrosis(CF)
4.1.4 Non-CF Bronchiectasis(NCFB)
4.1.5 Other
4.2 By Type - Global Alpha-1 Lung Disease Revenue & Forecasts
4.2.1 By Type - Global Alpha-1 Lung Disease Revenue, 2016-2021
4.2.2 By Type - Global Alpha-1 Lung Disease Revenue, 2022-2027
4.2.3 By Type - Global Alpha-1 Lung Disease Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Alpha-1 Lung Disease Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Pharmacies
5.1.5 Others
5.2 By Application - Global Alpha-1 Lung Disease Revenue & Forecasts
5.2.1 By Application - Global Alpha-1 Lung Disease Revenue, 2016-2021
5.2.2 By Application - Global Alpha-1 Lung Disease Revenue, 2022-2027
5.2.3 By Application - Global Alpha-1 Lung Disease Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Alpha-1 Lung Disease Market Size, 2021 & 2027
6.2 By Region - Global Alpha-1 Lung Disease Revenue & Forecasts
6.2.1 By Region - Global Alpha-1 Lung Disease Revenue, 2016-2021
6.2.2 By Region - Global Alpha-1 Lung Disease Revenue, 2022-2027
6.2.3 By Region - Global Alpha-1 Lung Disease Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Alpha-1 Lung Disease Revenue, 2016-2027
6.3.2 US Alpha-1 Lung Disease Market Size, 2016-2027
6.3.3 Canada Alpha-1 Lung Disease Market Size, 2016-2027
6.3.4 Mexico Alpha-1 Lung Disease Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Alpha-1 Lung Disease Revenue, 2016-2027
6.4.2 Germany Alpha-1 Lung Disease Market Size, 2016-2027
6.4.3 France Alpha-1 Lung Disease Market Size, 2016-2027
6.4.4 U.K. Alpha-1 Lung Disease Market Size, 2016-2027
6.4.5 Italy Alpha-1 Lung Disease Market Size, 2016-2027
6.4.6 Russia Alpha-1 Lung Disease Market Size, 2016-2027
6.4.7 Nordic Countries Alpha-1 Lung Disease Market Size, 2016-2027
6.4.8 Benelux Alpha-1 Lung Disease Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Alpha-1 Lung Disease Revenue, 2016-2027
6.5.2 China Alpha-1 Lung Disease Market Size, 2016-2027
6.5.3 Japan Alpha-1 Lung Disease Market Size, 2016-2027
6.5.4 South Korea Alpha-1 Lung Disease Market Size, 2016-2027
6.5.5 Southeast Asia Alpha-1 Lung Disease Market Size, 2016-2027
6.5.6 India Alpha-1 Lung Disease Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Alpha-1 Lung Disease Revenue, 2016-2027
6.6.2 Brazil Alpha-1 Lung Disease Market Size, 2016-2027
6.6.3 Argentina Alpha-1 Lung Disease Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Alpha-1 Lung Disease Revenue, 2016-2027
6.7.2 Turkey Alpha-1 Lung Disease Market Size, 2016-2027
6.7.3 Israel Alpha-1 Lung Disease Market Size, 2016-2027
6.7.4 Saudi Arabia Alpha-1 Lung Disease Market Size, 2016-2027
6.7.5 UAE Alpha-1 Lung Disease Market Size, 2016-2027
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Alpha-1 Lung Disease Major Product Offerings
7.1.4 Pfizer Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Baxter
7.2.1 Baxter Corporate Summary
7.2.2 Baxter Business Overview
7.2.3 Baxter Alpha-1 Lung Disease Major Product Offerings
7.2.4 Baxter Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.2.5 Baxter Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Alpha-1 Lung Disease Major Product Offerings
7.3.4 AstraZeneca Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.3.5 AstraZeneca Key News
7.4 Grifols
7.4.1 Grifols Corporate Summary
7.4.2 Grifols Business Overview
7.4.3 Grifols Alpha-1 Lung Disease Major Product Offerings
7.4.4 Grifols Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.4.5 Grifols Key News
7.5 Teva Pharmaceutical Industries
7.5.1 Teva Pharmaceutical Industries Corporate Summary
7.5.2 Teva Pharmaceutical Industries Business Overview
7.5.3 Teva Pharmaceutical Industries Alpha-1 Lung Disease Major Product Offerings
7.5.4 Teva Pharmaceutical Industries Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.5.5 Teva Pharmaceutical Industries Key News
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporate Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Alpha-1 Lung Disease Major Product Offerings
7.6.4 Boehringer Ingelheim Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.6.5 Boehringer Ingelheim Key News
7.7 Kamada Ltd
7.7.1 Kamada Ltd Corporate Summary
7.7.2 Kamada Ltd Business Overview
7.7.3 Kamada Ltd Alpha-1 Lung Disease Major Product Offerings
7.4.4 Kamada Ltd Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.7.5 Kamada Ltd Key News
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Alpha-1 Lung Disease Major Product Offerings
7.8.4 GlaxoSmithKline Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.8.5 GlaxoSmithKline Key News
7.9 CSL Behring
7.9.1 CSL Behring Corporate Summary
7.9.2 CSL Behring Business Overview
7.9.3 CSL Behring Alpha-1 Lung Disease Major Product Offerings
7.9.4 CSL Behring Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.9.5 CSL Behring Key News
7.10 Takeda
7.10.1 Takeda Corporate Summary
7.10.2 Takeda Business Overview
7.10.3 Takeda Alpha-1 Lung Disease Major Product Offerings
7.10.4 Takeda Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.10.5 Takeda Key News
7.11 LFB Biomedicaments
7.11.1 LFB Biomedicaments Corporate Summary
7.11.2 LFB Biomedicaments Business Overview
7.11.3 LFB Biomedicaments Alpha-1 Lung Disease Major Product Offerings
7.11.4 LFB Biomedicaments Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.11.5 LFB Biomedicaments Key News
7.12 Abeona Therapeutics
7.12.1 Abeona Therapeutics Corporate Summary
7.12.2 Abeona Therapeutics Business Overview
7.12.3 Abeona Therapeutics Alpha-1 Lung Disease Major Product Offerings
7.12.4 Abeona Therapeutics Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.12.5 Abeona Therapeutics Key News
7.13 Biogen
7.13.1 Biogen Corporate Summary
7.13.2 Biogen Business Overview
7.13.3 Biogen Alpha-1 Lung Disease Major Product Offerings
7.13.4 Biogen Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.13.5 Biogen Key News
7.14 Vertex Pharmaceuticals
7.14.1 Vertex Pharmaceuticals Corporate Summary
7.14.2 Vertex Pharmaceuticals Business Overview
7.14.3 Vertex Pharmaceuticals Alpha-1 Lung Disease Major Product Offerings
7.14.4 Vertex Pharmaceuticals Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.14.5 Vertex Pharmaceuticals Key News
7.15 Baxalta
7.15.1 Baxalta Corporate Summary
7.15.2 Baxalta Business Overview
7.15.3 Baxalta Alpha-1 Lung Disease Major Product Offerings
7.15.4 Baxalta Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.15.5 Baxalta Key News
7.16 Arrowhead Research Corporation
7.16.1 Arrowhead Research Corporation Corporate Summary
7.16.2 Arrowhead Research Corporation Business Overview
7.16.3 Arrowhead Research Corporation Alpha-1 Lung Disease Major Product Offerings
7.16.4 Arrowhead Research Corporation Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.16.5 Arrowhead Research Corporation Key News
7.17 ProBioGen
7.17.1 ProBioGen Corporate Summary
7.17.2 ProBioGen Business Overview
7.17.3 ProBioGen Alpha-1 Lung Disease Major Product Offerings
7.17.4 ProBioGen Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.17.5 ProBioGen Key News
7.18 Chiesi Pharmaceuticals
7.18.1 Chiesi Pharmaceuticals Corporate Summary
7.18.2 Chiesi Pharmaceuticals Business Overview
7.18.3 Chiesi Pharmaceuticals Alpha-1 Lung Disease Major Product Offerings
7.18.4 Chiesi Pharmaceuticals Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.18.5 Chiesi Pharmaceuticals Key News
7.19 Kedrion Group
7.19.1 Kedrion Group Corporate Summary
7.19.2 Kedrion Group Business Overview
7.19.3 Kedrion Group Alpha-1 Lung Disease Major Product Offerings
7.19.4 Kedrion Group Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.19.5 Kedrion Group Key News
7.20 ProMetic Life Sciences
7.20.1 ProMetic Life Sciences Corporate Summary
7.20.2 ProMetic Life Sciences Business Overview
7.20.3 ProMetic Life Sciences Alpha-1 Lung Disease Major Product Offerings
7.20.4 ProMetic Life Sciences Alpha-1 Lung Disease Revenue in Global (2016-2021)
7.20.5 ProMetic Life Sciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Alpha-1 Lung Disease Market Opportunities & Trends in Global Market
Table 2. Alpha-1 Lung Disease Market Drivers in Global Market
Table 3. Alpha-1 Lung Disease Market Restraints in Global Market
Table 4. Key Players of Alpha-1 Lung Disease in Global Market
Table 5. Top Alpha-1 Lung Disease Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Alpha-1 Lung Disease Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Alpha-1 Lung Disease Revenue Share by Companies, 2016-2021
Table 8. Global Companies Alpha-1 Lung Disease Product Type
Table 9. List of Global Tier 1 Alpha-1 Lung Disease Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alpha-1 Lung Disease Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Alpha-1 Lung Disease Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Alpha-1 Lung Disease Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Alpha-1 Lung Disease Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Alpha-1 Lung Disease Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Alpha-1 Lung Disease Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Alpha-1 Lung Disease Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Alpha-1 Lung Disease Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Alpha-1 Lung Disease Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Alpha-1 Lung Disease Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Alpha-1 Lung Disease Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Alpha-1 Lung Disease Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Alpha-1 Lung Disease Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Alpha-1 Lung Disease Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Alpha-1 Lung Disease Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Alpha-1 Lung Disease Product Offerings
Table 32. Pfizer Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 33. Baxter Corporate Summary
Table 34. Baxter Alpha-1 Lung Disease Product Offerings
Table 35. Baxter Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Alpha-1 Lung Disease Product Offerings
Table 38. AstraZeneca Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 39. Grifols Corporate Summary
Table 40. Grifols Alpha-1 Lung Disease Product Offerings
Table 41. Grifols Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 42. Teva Pharmaceutical Industries Corporate Summary
Table 43. Teva Pharmaceutical Industries Alpha-1 Lung Disease Product Offerings
Table 44. Teva Pharmaceutical Industries Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 45. Boehringer Ingelheim Corporate Summary
Table 46. Boehringer Ingelheim Alpha-1 Lung Disease Product Offerings
Table 47. Boehringer Ingelheim Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 48. Kamada Ltd Corporate Summary
Table 49. Kamada Ltd Alpha-1 Lung Disease Product Offerings
Table 50. Kamada Ltd Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 51. GlaxoSmithKline Corporate Summary
Table 52. GlaxoSmithKline Alpha-1 Lung Disease Product Offerings
Table 53. GlaxoSmithKline Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 54. CSL Behring Corporate Summary
Table 55. CSL Behring Alpha-1 Lung Disease Product Offerings
Table 56. CSL Behring Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 57. Takeda Corporate Summary
Table 58. Takeda Alpha-1 Lung Disease Product Offerings
Table 59. Takeda Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 60. LFB Biomedicaments Corporate Summary
Table 61. LFB Biomedicaments Alpha-1 Lung Disease Product Offerings
Table 62. LFB Biomedicaments Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 63. Abeona Therapeutics Corporate Summary
Table 64. Abeona Therapeutics Alpha-1 Lung Disease Product Offerings
Table 65. Abeona Therapeutics Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 66. Biogen Corporate Summary
Table 67. Biogen Alpha-1 Lung Disease Product Offerings
Table 68. Biogen Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 69. Vertex Pharmaceuticals Corporate Summary
Table 70. Vertex Pharmaceuticals Alpha-1 Lung Disease Product Offerings
Table 71. Vertex Pharmaceuticals Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 72. Baxalta Corporate Summary
Table 73. Baxalta Alpha-1 Lung Disease Product Offerings
Table 74. Baxalta Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 75. Arrowhead Research Corporation Corporate Summary
Table 76. Arrowhead Research Corporation Alpha-1 Lung Disease Product Offerings
Table 77. Arrowhead Research Corporation Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 78. ProBioGen Corporate Summary
Table 79. ProBioGen Alpha-1 Lung Disease Product Offerings
Table 80. ProBioGen Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 81. Chiesi Pharmaceuticals Corporate Summary
Table 82. Chiesi Pharmaceuticals Alpha-1 Lung Disease Product Offerings
Table 83. Chiesi Pharmaceuticals Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 84. Kedrion Group Corporate Summary
Table 85. Kedrion Group Alpha-1 Lung Disease Product Offerings
Table 86. Kedrion Group Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
Table 87. ProMetic Life Sciences Corporate Summary
Table 88. ProMetic Life Sciences Alpha-1 Lung Disease Product Offerings
Table 89. ProMetic Life Sciences Alpha-1 Lung Disease Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Alpha-1 Lung Disease Segment by Type
Figure 2. Alpha-1 Lung Disease Segment by Application
Figure 3. Global Alpha-1 Lung Disease Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Alpha-1 Lung Disease Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Alpha-1 Lung Disease Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alpha-1 Lung Disease Revenue in 2020
Figure 8. By Type - Global Alpha-1 Lung Disease Revenue Market Share, 2016-2027
Figure 9. By Application - Global Alpha-1 Lung Disease Revenue Market Share, 2016-2027
Figure 10. By Region - Global Alpha-1 Lung Disease Revenue Market Share, 2016-2027
Figure 11. By Country - North America Alpha-1 Lung Disease Revenue Market Share, 2016-2027
Figure 12. US Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Alpha-1 Lung Disease Revenue Market Share, 2016-2027
Figure 16. Germany Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 17. France Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Alpha-1 Lung Disease Revenue Market Share, 2016-2027
Figure 24. China Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 28. India Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Alpha-1 Lung Disease Revenue Market Share, 2016-2027
Figure 30. Brazil Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Alpha-1 Lung Disease Revenue Market Share, 2016-2027
Figure 33. Turkey Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Alpha-1 Lung Disease Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Baxter Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. AstraZeneca Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Grifols Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Teva Pharmaceutical Industries Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Boehringer Ingelheim Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Kamada Ltd Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. GlaxoSmithKline Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. CSL Behring Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Takeda Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. LFB Biomedicaments Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Abeona Therapeutics Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Biogen Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Vertex Pharmaceuticals Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Baxalta Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Arrowhead Research Corporation Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. ProBioGen Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Chiesi Pharmaceuticals Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Kedrion Group Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. ProMetic Life Sciences Alpha-1 Lung Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs